Background Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback